Leroy Shervington

508 total citations
25 papers, 416 citations indexed

About

Leroy Shervington is a scholar working on Molecular Biology, Physiology and Immunology. According to data from OpenAlex, Leroy Shervington has authored 25 papers receiving a total of 416 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 5 papers in Physiology and 4 papers in Immunology. Recurrent topics in Leroy Shervington's work include Heat shock proteins research (7 papers), Telomeres, Telomerase, and Senescence (4 papers) and Toxin Mechanisms and Immunotoxins (4 papers). Leroy Shervington is often cited by papers focused on Heat shock proteins research (7 papers), Telomeres, Telomerase, and Senescence (4 papers) and Toxin Mechanisms and Immunotoxins (4 papers). Leroy Shervington collaborates with scholars based in United Kingdom, Jordan and Poland. Leroy Shervington's co-authors include Amal Shervington, James G. Donnelly, Robert Lea, Rahima Patel, Nichola Cruickshanks, Gareth Roberts, Chinmay Munje, Lü Chen, Dipti Thakkar and Rebecca Atkinson-Dell and has published in prestigious journals such as Brain Research, Molecules and Phytochemistry.

In The Last Decade

Leroy Shervington

25 papers receiving 407 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leroy Shervington United Kingdom 12 189 69 66 65 58 25 416
Yuesheng Xia China 10 129 0.7× 42 0.6× 38 0.6× 25 0.4× 37 0.6× 13 432
Steve W. Preece United States 9 152 0.8× 50 0.7× 98 1.5× 13 0.2× 98 1.7× 10 478
Prabal Subedi Germany 11 161 0.9× 54 0.8× 65 1.0× 27 0.4× 67 1.2× 19 368
Alicja K. Olejnik Poland 14 173 0.9× 51 0.7× 96 1.5× 10 0.2× 41 0.7× 24 583
Fanglin Yu China 15 327 1.7× 27 0.4× 174 2.6× 19 0.3× 27 0.5× 35 693
S. Shantikumar India 8 148 0.8× 61 0.9× 69 1.0× 16 0.2× 40 0.7× 9 428
Lei Tian China 11 104 0.6× 42 0.6× 53 0.8× 28 0.4× 18 0.3× 37 373
Yuri Nishimura Japan 12 242 1.3× 31 0.4× 59 0.9× 19 0.3× 19 0.3× 19 472
Malek Hossein Asadi Iran 14 420 2.2× 38 0.6× 55 0.8× 14 0.2× 20 0.3× 34 715
Fuyan Liu China 16 203 1.1× 16 0.2× 29 0.4× 40 0.6× 6 0.1× 35 541

Countries citing papers authored by Leroy Shervington

Since Specialization
Citations

This map shows the geographic impact of Leroy Shervington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leroy Shervington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leroy Shervington more than expected).

Fields of papers citing papers by Leroy Shervington

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leroy Shervington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leroy Shervington. The network helps show where Leroy Shervington may publish in the future.

Co-authorship network of co-authors of Leroy Shervington

This figure shows the co-authorship network connecting the top 25 collaborators of Leroy Shervington. A scholar is included among the top collaborators of Leroy Shervington based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leroy Shervington. Leroy Shervington is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Shervington, Leroy, Rober Habashy, Beatriz C. Pereira, et al.. (2020). Temperature and solvent facilitated extrusion based 3D printing for pharmaceuticals. European Journal of Pharmaceutical Sciences. 152. 105430–105430. 33 indexed citations
3.
Shervington, Leroy, et al.. (2018). A Comparative HPLC Analysis of Myricetin, Quercetin and Kaempferol Flavonoids Isolated From Gambian and Indian Moringa oleifera Leaves. International Journal of Chemistry. 10(4). 28–28. 19 indexed citations
4.
Shervington, Leroy, et al.. (2018). Identifying Reliable Diagnostic/Predictive Biomarkers for Rheumatoid Arthritis. Biomarker Insights. 13. 4203098221–4203098221. 17 indexed citations
5.
Shervington, Leroy, et al.. (2015). Could the Anti-Chaperone VER155008 Replace Temozolomide for Glioma Treatment. Journal of Cancer. 6(8). 786–794. 8 indexed citations
6.
Munje, Chinmay, et al.. (2014). Could Upregulated Hsp70 Protein Compensate for the Hsp90-Silence-Induced Cell Death in Glioma Cells?. CLOK (University of Central Lancashire). 2014. 1–9. 7 indexed citations
7.
Shervington, Amal, et al.. (2013). Can RNAi‐mediated hsp90α knockdown in combination with 17‐AAG be a therapy for glioma?. FEBS Open Bio. 3(1). 271–278. 4 indexed citations
8.
Shervington, Amal, et al.. (2013). The Complexity of Identifying Cancer Stem Cell Biomarkers. Cancer Investigation. 31(6). 404–411. 7 indexed citations
9.
Shervington, Leroy, et al.. (2011). A Novel Therapeutic Strategy for the Treatment of Glioma, Combining Chemical and Molecular Targeting of Hsp90a. Cancers. 3(4). 4228–4244. 10 indexed citations
10.
Thakkar, Dipti, Leroy Shervington, & Amal Shervington. (2011). Proteomic Studies Coupled with RNAi Methodologies can Shed Further Light on the Downstream Effects of Telomerase in Glioma. Cancer Investigation. 29(2). 113–122. 6 indexed citations
11.
Cruickshanks, Nichola, Leroy Shervington, Rahima Patel, et al.. (2010). Can hsp90α-Targeted siRNA Combined With TMZ Be a Future Therapy for Glioma?. Cancer Investigation. 28(6). 608–614. 16 indexed citations
12.
Shervington, Amal, Lü Chen, Rahima Patel, & Leroy Shervington. (2009). Telomerase downregulation in cancer brain stem cell. Molecular and Cellular Biochemistry. 331(1-2). 153–159. 13 indexed citations
13.
Shervington, Amal, et al.. (2008). Can The Lack of HSP90α Protein in Brain Normal Tissue and Cell Lines, Rationalise it as a Possible Therapeutic Target for Gliomas?. Cancer Investigation. 26(9). 900–904. 10 indexed citations
14.
Shervington, Leroy, Nigel Smith, Emma S. Norman, et al.. (2008). To determine the cytotoxicity of chlorambucil and one of its nitro-derivatives, conjugated to prasterone and pregnenolone, towards eight human cancer cell-lines. European Journal of Medicinal Chemistry. 44(7). 2944–2951. 25 indexed citations
15.
Shervington, Amal, Rahima Patel, Lü Chen, et al.. (2007). Telomerase subunits expression variation between biopsy samples and cell lines derived from malignant glioma. Brain Research. 1134(1). 45–52. 39 indexed citations
16.
Patel, Rahima, Leroy Shervington, Robert Lea, & Amal Shervington. (2007). Epigenetic silencing of telomerase and a non-alkylating agent as a novel therapeutic approach for glioma. Brain Research. 1188. 173–181. 21 indexed citations
17.
Shervington, Amal, Nichola Cruickshanks, Rebecca Atkinson-Dell, et al.. (2006). Glioma: What is the role of c-Myc, hsp90 and telomerase?. Molecular and Cellular Biochemistry. 283(1-2). 1–9. 34 indexed citations
18.
Shervington, Leroy, et al.. (2005). The simultaneous separation and determination of five quinolone antibotics using isocratic reversed-phase HPLC: Application to stability studies on an ofloxacin tablet formulation. Journal of Pharmaceutical and Biomedical Analysis. 39(3-4). 769–775. 70 indexed citations
19.
Shervington, Leroy, et al.. (2000). A quantitative and qualitative high performance liquid chromatographic determination of acetaminophen and five of its para-substituted derivatives. Journal of Pharmaceutical and Biomedical Analysis. 24(1). 43–49. 23 indexed citations
20.
Shervington, Amal, et al.. (1998). Caffeine and theobromine formation by tissue cultures of Camellia sinensis. Phytochemistry. 47(8). 1535–1536. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuesheng Xia Breakdown of academic impact, for papers by Steve W. Preece Breakdown of academic impact, for papers by Prabal Subedi Breakdown of academic impact, for papers by Alicja K. Olejnik Breakdown of academic impact, for papers by Fanglin Yu Breakdown of academic impact, for papers by S. Shantikumar Breakdown of academic impact, for papers by Lei Tian Breakdown of academic impact, for papers by Yuri Nishimura Breakdown of academic impact, for papers by Malek Hossein Asadi Breakdown of academic impact, for papers by Fuyan Liu
Rankless by CCL
2026